Search the Site


test tubes

$AMRN Amarin Moves Up Clinical Timelines, Again

publication date: Nov 10, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Amarin (NASDAQ:AMRN) reported its quarterly financial results for 3Q10 this morning along with positive updates for its clinical development timeline for AMR101 and corporate developments.

Sorry this page is available to subscribers only. 

You can also sign up for our 100% FREE Newsletter  to stay current on public webinars, special offers, and news alerts:


If you are already a subscriber, please login.

To gain access to the members only content click here to subscribe.

If you believe you should be able to view this area then please contact us and we will try to rectify this issue as soon as possible.